Structure

Physi-Chem Properties

Molecular Weight:  584.37
Volume:  625.403
LogP:  6.157
LogD:  4.16
LogS:  -5.28
# Rotatable Bonds:  14
TPSA:  110.13
# H-Bond Aceptor:  7
# H-Bond Donor:  2
# Rings:  4
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.125
Synthetic Accessibility Score:  5.157
Fsp3:  0.743
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.816
MDCK Permeability:  1.586776488693431e-05
Pgp-inhibitor:  0.999
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.028
20% Bioavailability (F20%):  0.752
30% Bioavailability (F30%):  0.798

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.384
Plasma Protein Binding (PPB):  93.35672760009766%
Volume Distribution (VD):  1.424
Pgp-substrate:  2.4849984645843506%

ADMET: Metabolism

CYP1A2-inhibitor:  0.068
CYP1A2-substrate:  0.128
CYP2C19-inhibitor:  0.806
CYP2C19-substrate:  0.25
CYP2C9-inhibitor:  0.927
CYP2C9-substrate:  0.106
CYP2D6-inhibitor:  0.602
CYP2D6-substrate:  0.031
CYP3A4-inhibitor:  0.948
CYP3A4-substrate:  0.201

ADMET: Excretion

Clearance (CL):  8.264
Half-life (T1/2):  0.365

ADMET: Toxicity

hERG Blockers:  0.899
Human Hepatotoxicity (H-HT):  0.981
Drug-inuced Liver Injury (DILI):  0.668
AMES Toxicity:  0.01
Rat Oral Acute Toxicity:  0.712
Maximum Recommended Daily Dose:  0.967
Skin Sensitization:  0.844
Carcinogencity:  0.014
Eye Corrosion:  0.003
Eye Irritation:  0.011
Respiratory Toxicity:  0.965

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC107197

Natural Product ID:  NPC107197
Common Name*:   Omubioside
IUPAC Name:   3-[2,2-dimethyl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-6-yl]propanoic acid
Synonyms:   omubioside
Standard InCHIKey:  NQAQCZORTDQVFT-LMYULTQQSA-N
Standard InCHI:  InChI=1S/C26H36O14/c1-26(2)8-7-12-13(40-26)5-3-11(4-6-16(28)29)23(12)39-25-22(35)20(33)18(31)15(38-25)10-36-24-21(34)19(32)17(30)14(9-27)37-24/h3,5,7-8,14-15,17-22,24-25,27,30-35H,4,6,9-10H2,1-2H3,(H,28,29)/t14-,15-,17-,18-,19+,20+,21-,22-,24-,25+/m1/s1
SMILES:  OC[C@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(CCC(=O)O)ccc4c3C=CC(O4)(C)C)[C@@H]([C@H]([C@@H]2O)O)O)[C@@H]([C@H]([C@@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1928406
PubChem CID:   56602471
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0000011] Carbohydrates and carbohydrate conjugates
          • [CHEMONTID:0002105] Glycosyl compounds
            • [CHEMONTID:0004165] Phenolic glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO1762 Citropsis articulata Species Rutaceae Eukaryota Root Bark n.a. n.a. PMID[21985060]
NPO1762 Citropsis articulata Species Rutaceae Eukaryota n.a. root n.a. PMID[21985060]
NPO1762 Citropsis articulata Species Rutaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT189 Cell Line Vero Chlorocebus aethiops IC50 > 50.0 ug.mL-1 PMID[566521]
NPT1225 Organism Plasmodium falciparum (isolate FcB1 / Columbia) Plasmodium falciparum FcB1/Columbia IC50 > 100.0 ug.mL-1 PMID[566521]
NPT633 Organism Leishmania donovani Leishmania donovani EC50 > 125.0 ug.mL-1 PMID[566521]
NPT471 Organism Trypanosoma brucei brucei Trypanosoma brucei brucei EC50 > 125.0 ug.mL-1 PMID[566521]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC107197 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9379 High Similarity NPC469700
0.9116 High Similarity NPC87950
0.9116 High Similarity NPC471764
0.898 High Similarity NPC85624
0.8944 High Similarity NPC34456
0.8919 High Similarity NPC74320
0.8919 High Similarity NPC107120
0.8859 High Similarity NPC296377
0.8854 High Similarity NPC124155
0.8854 High Similarity NPC257566
0.8846 High Similarity NPC101636
0.8839 High Similarity NPC43761
0.8831 High Similarity NPC295613
0.8831 High Similarity NPC17521
0.8831 High Similarity NPC473657
0.8824 High Similarity NPC108706
0.8824 High Similarity NPC268950
0.8824 High Similarity NPC211158
0.8824 High Similarity NPC78021
0.8824 High Similarity NPC87304
0.8808 High Similarity NPC100818
0.8803 High Similarity NPC269421
0.88 High Similarity NPC169510
0.8792 High Similarity NPC474044
0.879 High Similarity NPC190450
0.879 High Similarity NPC298171
0.879 High Similarity NPC44947
0.8766 High Similarity NPC470604
0.8766 High Similarity NPC470605
0.8766 High Similarity NPC470603
0.875 High Similarity NPC213723
0.8734 High Similarity NPC183672
0.8726 High Similarity NPC47923
0.8725 High Similarity NPC226722
0.8718 High Similarity NPC138811
0.8718 High Similarity NPC473634
0.8718 High Similarity NPC470607
0.8718 High Similarity NPC22062
0.8716 High Similarity NPC116922
0.8716 High Similarity NPC469367
0.871 High Similarity NPC206378
0.871 High Similarity NPC127406
0.871 High Similarity NPC45165
0.8696 High Similarity NPC76047
0.8679 High Similarity NPC294722
0.8679 High Similarity NPC475979
0.8675 High Similarity NPC472339
0.8671 High Similarity NPC131745
0.8671 High Similarity NPC259834
0.8662 High Similarity NPC271270
0.8662 High Similarity NPC142860
0.8662 High Similarity NPC472320
0.8662 High Similarity NPC473623
0.8662 High Similarity NPC97285
0.8662 High Similarity NPC246469
0.8658 High Similarity NPC177597
0.8658 High Similarity NPC225445
0.8654 High Similarity NPC473512
0.8654 High Similarity NPC129827
0.8654 High Similarity NPC44931
0.8654 High Similarity NPC23817
0.8654 High Similarity NPC43638
0.8654 High Similarity NPC470606
0.8654 High Similarity NPC65003
0.8649 High Similarity NPC128337
0.8649 High Similarity NPC84207
0.8649 High Similarity NPC5253
0.8649 High Similarity NPC139976
0.8649 High Similarity NPC230718
0.8649 High Similarity NPC49542
0.8645 High Similarity NPC27408
0.8645 High Similarity NPC26195
0.8645 High Similarity NPC95090
0.8645 High Similarity NPC39351
0.8645 High Similarity NPC169248
0.8645 High Similarity NPC72649
0.8645 High Similarity NPC97052
0.8639 High Similarity NPC312881
0.8634 High Similarity NPC5319
0.863 High Similarity NPC87777
0.863 High Similarity NPC471069
0.863 High Similarity NPC262328
0.863 High Similarity NPC471068
0.8627 High Similarity NPC38775
0.8627 High Similarity NPC191154
0.8625 High Similarity NPC262222
0.8625 High Similarity NPC298666
0.8625 High Similarity NPC68592
0.8625 High Similarity NPC64425
0.8616 High Similarity NPC179198
0.8616 High Similarity NPC66087
0.8616 High Similarity NPC278419
0.8616 High Similarity NPC121703
0.8608 High Similarity NPC129217
0.8608 High Similarity NPC224530
0.8608 High Similarity NPC48093
0.8608 High Similarity NPC303913
0.8608 High Similarity NPC259957
0.8608 High Similarity NPC216496
0.8608 High Similarity NPC85707
0.8608 High Similarity NPC159579
0.86 High Similarity NPC469701
0.8599 High Similarity NPC73511
0.859 High Similarity NPC170475
0.8581 High Similarity NPC143851
0.8581 High Similarity NPC39360
0.8581 High Similarity NPC152771
0.8581 High Similarity NPC215512
0.8581 High Similarity NPC287286
0.8581 High Similarity NPC83283
0.8581 High Similarity NPC80098
0.8581 High Similarity NPC195357
0.8581 High Similarity NPC476442
0.8581 High Similarity NPC29763
0.8581 High Similarity NPC106625
0.8581 High Similarity NPC210003
0.858 High Similarity NPC138990
0.858 High Similarity NPC277532
0.858 High Similarity NPC175429
0.858 High Similarity NPC209550
0.8571 High Similarity NPC471072
0.8571 High Similarity NPC23253
0.8571 High Similarity NPC134819
0.8571 High Similarity NPC471070
0.8571 High Similarity NPC471071
0.8571 High Similarity NPC250488
0.8562 High Similarity NPC103116
0.8562 High Similarity NPC103409
0.8562 High Similarity NPC104172
0.8562 High Similarity NPC72016
0.8562 High Similarity NPC88886
0.8553 High Similarity NPC240306
0.8553 High Similarity NPC475382
0.8553 High Similarity NPC27942
0.8553 High Similarity NPC472876
0.8553 High Similarity NPC244875
0.8553 High Similarity NPC218685
0.8552 High Similarity NPC471029
0.8544 High Similarity NPC153342
0.8544 High Similarity NPC187379
0.8544 High Similarity NPC200708
0.8537 High Similarity NPC63105
0.8535 High Similarity NPC122809
0.8535 High Similarity NPC313163
0.8535 High Similarity NPC108831
0.8535 High Similarity NPC161749
0.8535 High Similarity NPC182634
0.8535 High Similarity NPC60966
0.8535 High Similarity NPC197896
0.8535 High Similarity NPC156457
0.8535 High Similarity NPC258035
0.8533 High Similarity NPC471028
0.8526 High Similarity NPC99233
0.8516 High Similarity NPC256141
0.8516 High Similarity NPC121001
0.8516 High Similarity NPC259182
0.8506 High Similarity NPC106025
0.8506 High Similarity NPC477240
0.8506 High Similarity NPC214454
0.8503 High Similarity NPC155963
0.8503 High Similarity NPC232246
0.8503 High Similarity NPC153818
0.85 High Similarity NPC311850
0.85 High Similarity NPC473644
0.8497 Intermediate Similarity NPC199335
0.8491 Intermediate Similarity NPC476215
0.8491 Intermediate Similarity NPC249281
0.8491 Intermediate Similarity NPC477629
0.8491 Intermediate Similarity NPC163242
0.8491 Intermediate Similarity NPC173582
0.8491 Intermediate Similarity NPC270675
0.8491 Intermediate Similarity NPC282169
0.8491 Intermediate Similarity NPC473438
0.8491 Intermediate Similarity NPC246943
0.8491 Intermediate Similarity NPC276377
0.8491 Intermediate Similarity NPC181465
0.8491 Intermediate Similarity NPC139320
0.8491 Intermediate Similarity NPC195685
0.8491 Intermediate Similarity NPC472994
0.8491 Intermediate Similarity NPC116458
0.8491 Intermediate Similarity NPC210961
0.8491 Intermediate Similarity NPC477628
0.8491 Intermediate Similarity NPC215710
0.8491 Intermediate Similarity NPC253788
0.8491 Intermediate Similarity NPC265885
0.8487 Intermediate Similarity NPC474302
0.8485 Intermediate Similarity NPC325176
0.8481 Intermediate Similarity NPC308265
0.8481 Intermediate Similarity NPC320283
0.8481 Intermediate Similarity NPC41121
0.8481 Intermediate Similarity NPC472459
0.8481 Intermediate Similarity NPC111929
0.8481 Intermediate Similarity NPC104677
0.8476 Intermediate Similarity NPC208668
0.8471 Intermediate Similarity NPC203500
0.8471 Intermediate Similarity NPC165483
0.8471 Intermediate Similarity NPC307938
0.8471 Intermediate Similarity NPC323593
0.8466 Intermediate Similarity NPC210808
0.8466 Intermediate Similarity NPC78734

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC107197 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8634 High Similarity NPD7804 Clinical (unspecified phase)
0.8581 High Similarity NPD8455 Phase 2
0.8535 High Similarity NPD4381 Clinical (unspecified phase)
0.8403 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.8293 Intermediate Similarity NPD7054 Approved
0.8242 Intermediate Similarity NPD7472 Approved
0.8242 Intermediate Similarity NPD7074 Phase 3
0.8228 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8187 Intermediate Similarity NPD7075 Discontinued
0.8165 Intermediate Similarity NPD6801 Discontinued
0.8153 Intermediate Similarity NPD4380 Phase 2
0.8144 Intermediate Similarity NPD7251 Discontinued
0.8108 Intermediate Similarity NPD5124 Phase 1
0.8108 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.8095 Intermediate Similarity NPD7808 Phase 3
0.8084 Intermediate Similarity NPD6797 Phase 2
0.8037 Intermediate Similarity NPD7199 Phase 2
0.8012 Intermediate Similarity NPD7228 Approved
0.8 Intermediate Similarity NPD7097 Phase 1
0.7988 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7987 Intermediate Similarity NPD7411 Suspended
0.7929 Intermediate Similarity NPD6559 Discontinued
0.7911 Intermediate Similarity NPD1653 Approved
0.7904 Intermediate Similarity NPD3818 Discontinued
0.7902 Intermediate Similarity NPD1091 Approved
0.7901 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7888 Intermediate Similarity NPD7819 Suspended
0.7875 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7857 Intermediate Similarity NPD1652 Phase 2
0.7831 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7829 Intermediate Similarity NPD7033 Discontinued
0.7826 Intermediate Similarity NPD37 Approved
0.7824 Intermediate Similarity NPD7240 Approved
0.7791 Intermediate Similarity NPD4965 Approved
0.7791 Intermediate Similarity NPD4966 Approved
0.7791 Intermediate Similarity NPD4967 Phase 2
0.7785 Intermediate Similarity NPD6798 Discontinued
0.7778 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD6799 Approved
0.7751 Intermediate Similarity NPD5844 Phase 1
0.7736 Intermediate Similarity NPD5403 Approved
0.773 Intermediate Similarity NPD3817 Phase 2
0.773 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7722 Intermediate Similarity NPD5401 Approved
0.7722 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7722 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7697 Intermediate Similarity NPD6234 Discontinued
0.7679 Intermediate Similarity NPD6166 Phase 2
0.7679 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7679 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7665 Intermediate Similarity NPD3787 Discontinued
0.7663 Intermediate Similarity NPD7583 Approved
0.7632 Intermediate Similarity NPD6355 Discontinued
0.7628 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7627 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7622 Intermediate Similarity NPD7585 Approved
0.7616 Intermediate Similarity NPD6233 Phase 2
0.7613 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7613 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7607 Intermediate Similarity NPD1934 Approved
0.7593 Intermediate Similarity NPD6599 Discontinued
0.758 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.758 Intermediate Similarity NPD4628 Phase 3
0.7564 Intermediate Similarity NPD1549 Phase 2
0.7558 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.755 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7548 Intermediate Similarity NPD2796 Approved
0.7529 Intermediate Similarity NPD8313 Approved
0.7529 Intermediate Similarity NPD8312 Approved
0.7516 Intermediate Similarity NPD6674 Discontinued
0.7515 Intermediate Similarity NPD5402 Approved
0.75 Intermediate Similarity NPD7266 Discontinued
0.75 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7473 Intermediate Similarity NPD7584 Approved
0.7471 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.747 Intermediate Similarity NPD7768 Phase 2
0.7468 Intermediate Similarity NPD3750 Approved
0.7456 Intermediate Similarity NPD7229 Phase 3
0.7452 Intermediate Similarity NPD2424 Discontinued
0.7451 Intermediate Similarity NPD1613 Approved
0.7451 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.744 Intermediate Similarity NPD5494 Approved
0.7436 Intermediate Similarity NPD6099 Approved
0.7436 Intermediate Similarity NPD6100 Approved
0.7423 Intermediate Similarity NPD7458 Discontinued
0.7417 Intermediate Similarity NPD4908 Phase 1
0.7415 Intermediate Similarity NPD422 Phase 1
0.7414 Intermediate Similarity NPD7685 Pre-registration
0.7407 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7396 Intermediate Similarity NPD6959 Discontinued
0.7389 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD6004 Phase 3
0.7389 Intermediate Similarity NPD6002 Phase 3
0.7389 Intermediate Similarity NPD6005 Phase 3
0.7389 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7384 Intermediate Similarity NPD3751 Discontinued
0.7375 Intermediate Similarity NPD5058 Phase 3
0.7372 Intermediate Similarity NPD3748 Approved
0.7358 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7349 Intermediate Similarity NPD2801 Approved
0.7349 Intermediate Similarity NPD1465 Phase 2
0.7345 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD2797 Approved
0.7329 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.732 Intermediate Similarity NPD1296 Phase 2
0.732 Intermediate Similarity NPD3268 Approved
0.7316 Intermediate Similarity NPD7783 Phase 2
0.7316 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7301 Intermediate Similarity NPD920 Approved
0.7273 Intermediate Similarity NPD4062 Phase 3
0.7268 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD8651 Approved
0.7267 Intermediate Similarity NPD3225 Approved
0.7261 Intermediate Similarity NPD1510 Phase 2
0.726 Intermediate Similarity NPD1548 Phase 1
0.7251 Intermediate Similarity NPD6232 Discontinued
0.7233 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD7473 Discontinued
0.7222 Intermediate Similarity NPD1511 Approved
0.7219 Intermediate Similarity NPD7435 Discontinued
0.7211 Intermediate Similarity NPD8151 Discontinued
0.7208 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7203 Intermediate Similarity NPD7843 Approved
0.719 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7189 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD1243 Approved
0.7181 Intermediate Similarity NPD1610 Phase 2
0.7178 Intermediate Similarity NPD2534 Approved
0.7178 Intermediate Similarity NPD2533 Approved
0.7178 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7178 Intermediate Similarity NPD8389 Clinical (unspecified phase)
0.7178 Intermediate Similarity NPD2532 Approved
0.716 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD3027 Phase 3
0.7143 Intermediate Similarity NPD7095 Approved
0.7134 Intermediate Similarity NPD1512 Approved
0.7133 Intermediate Similarity NPD1608 Approved
0.7128 Intermediate Similarity NPD7680 Approved
0.7124 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD3749 Approved
0.7115 Intermediate Similarity NPD1240 Approved
0.7115 Intermediate Similarity NPD4060 Phase 1
0.7108 Intermediate Similarity NPD8158 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD3266 Approved
0.7105 Intermediate Similarity NPD3267 Approved
0.7099 Intermediate Similarity NPD6190 Approved
0.7093 Intermediate Similarity NPD8127 Discontinued
0.7089 Intermediate Similarity NPD4978 Clinical (unspecified phase)
0.7089 Intermediate Similarity NPD4538 Approved
0.7089 Intermediate Similarity NPD4536 Approved
0.7089 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7081 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7078 Intermediate Similarity NPD6832 Phase 2
0.7076 Intermediate Similarity NPD919 Approved
0.707 Intermediate Similarity NPD1933 Approved
0.7063 Intermediate Similarity NPD5762 Approved
0.7063 Intermediate Similarity NPD5763 Approved
0.7059 Intermediate Similarity NPD6778 Approved
0.7059 Intermediate Similarity NPD6781 Approved
0.7059 Intermediate Similarity NPD6776 Approved
0.7059 Intermediate Similarity NPD6780 Approved
0.7059 Intermediate Similarity NPD3882 Suspended
0.7059 Intermediate Similarity NPD6782 Approved
0.7059 Intermediate Similarity NPD6779 Approved
0.7059 Intermediate Similarity NPD6777 Approved
0.7055 Intermediate Similarity NPD7157 Approved
0.7047 Intermediate Similarity NPD1778 Approved
0.7045 Intermediate Similarity NPD7286 Phase 2
0.7042 Intermediate Similarity NPD2684 Approved
0.7037 Intermediate Similarity NPD7696 Phase 3
0.7037 Intermediate Similarity NPD7697 Approved
0.7037 Intermediate Similarity NPD7698 Approved
0.7032 Intermediate Similarity NPD4625 Phase 3
0.7027 Intermediate Similarity NPD1894 Discontinued
0.7025 Intermediate Similarity NPD1607 Approved
0.7025 Intermediate Similarity NPD6653 Approved
0.7025 Intermediate Similarity NPD6651 Approved
0.7006 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD2935 Discontinued
0.7 Intermediate Similarity NPD4477 Approved
0.7 Intermediate Similarity NPD1551 Phase 2
0.7 Intermediate Similarity NPD4476 Approved
0.6995 Remote Similarity NPD7874 Approved
0.6995 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6987 Remote Similarity NPD2313 Discontinued
0.6979 Remote Similarity NPD7701 Phase 2
0.6975 Remote Similarity NPD2800 Approved
0.6974 Remote Similarity NPD4749 Approved
0.6972 Remote Similarity NPD290 Approved
0.6968 Remote Similarity NPD1008 Clinical (unspecified phase)
0.6966 Remote Similarity NPD5953 Discontinued
0.6962 Remote Similarity NPD230 Phase 1
0.6948 Remote Similarity NPD5647 Approved
0.694 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6937 Remote Similarity NPD2799 Discontinued
0.6937 Remote Similarity NPD4308 Phase 3
0.6937 Remote Similarity NPD5588 Approved
0.6937 Remote Similarity NPD5960 Phase 3
0.6933 Remote Similarity NPD17 Approved
0.6923 Remote Similarity NPD8434 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data